BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 9202219)

  • 1. Expression of urokinase-type plasminogen activator and its receptor during ovarian follicular development.
    Li M; Karakji EG; Xing R; Fryer JN; Carnegie JA; Rabbani SA; Tsang BK
    Endocrinology; 1997 Jul; 138(7):2790-9. PubMed ID: 9202219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
    Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
    J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle.
    Cao M; Buratini J; Lussier JG; Carrière PD; Price CA
    Reproduction; 2006 Jan; 131(1):125-37. PubMed ID: 16388016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type 1 are coordinately expressed during ovulation in the rhesus monkey.
    Liu YX; Liu K; Feng Q; Hu ZY; Liu HZ; Fu GQ; Li YC; Zou RJ; Ny T
    Endocrinology; 2004 Apr; 145(4):1767-75. PubMed ID: 14701676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of avian urokinase and tissue-type plasminogen activator messenger ribonucleic acid during follicle development and atresia.
    Johnson AL; Bridgham JT; Anthony RV
    Biol Reprod; 1997 Mar; 56(3):581-8. PubMed ID: 9047000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue.
    Dow MP; Bakke LJ; Cassar CA; Peters MW; Pursley JR; Smith GW
    Biol Reprod; 2002 May; 66(5):1413-21. PubMed ID: 11967205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotrophin surge-induced upregulation of mRNA for plasminogen activator inhibitors 1 and 2 within bovine periovulatory follicular and luteal tissue.
    Dow MP; Bakke LJ; Cassar CA; Peters MW; Pursley JR; Smith GW
    Reproduction; 2002 May; 123(5):711-9. PubMed ID: 12006099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spitz naevi may express components of the plasminogen activation system.
    Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ
    J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of rat granulosa cell plasminogen activator system: influence of interleukin-1 beta and ovarian follicular development.
    Karakji EG; Tsang BK
    Biol Reprod; 1995 Dec; 53(6):1302-10. PubMed ID: 8562685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2007 Dec; 45(8):623-7. PubMed ID: 17590247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J; Mizokami Y; Takahashi K; Nakajima K; Ohtsubo T; Miura S; Narasaka T; Takeyama H; Omata T; Shimokobe K; Ito M; Takehara H; Matsuoka T
    Scand J Gastroenterol; 2005 Jul; 40(7):783-93. PubMed ID: 16109653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
    Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
    Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific and time-coordinated hormone regulation of plasminogen-activator-inhibitor type I and tissue-type plasminogen activator in the rat ovary during gonadotropin-induced ovulation.
    Liu YX; Peng XR; Ny T
    Eur J Biochem; 1991 Jan; 195(2):549-55. PubMed ID: 1900052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient and cell-specific expression of tissue-type plasminogen activator and plasminogen-activator-inhibitor type 1 results in controlled and directed proteolysis during gonadotropin-induced ovulation.
    Peng XR; Hsueh AJ; Ny T
    Eur J Biochem; 1993 May; 214(1):147-56. PubMed ID: 8508786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS; Kwaan HC; Svoboda KM; Weiss IM; Sakurai S; Jordan VC
    Br J Cancer; 1998 Jul; 78(1):88-95. PubMed ID: 9662256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.